Purchase Order HHSF223201510380P
Award Date 7/13/15
Potential Completion Date 9/30/15
Potential Value $217K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The U.S. National Institute of Diabetes and Digestive and Kidney Diseases awarded a $9,426.00 firm-fixed-price purchase order to Seahorse Bioscience, Inc. for time and materials repair and maintenance of the XF Analyzer. This award was not set aside. Seahorse Bioscience, Inc. is a for-profit manufacturer of goods. The award was made on July 17, 2015, with a completion date of July 20, 2015.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Seahorse Bioscience, Inc. on August 7, 2013. The contract has a ceiling value of $7,343.10 and a period of performance through August 6, 2014. The contract does not have a set-aside designation. Seahorse Bioscience, Inc., doing business as Seahorse Labware, is the prime contractor. The contract is for the delivery of unspecified products or...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $2,942 purchase order to Seahorse Bioscience, Inc., doing business as Seahorse Labware, a subsidiary of Agilent Technologies, Inc. The firm fixed price contract is for maintenance services on the Seahorse XF96 instrument and will be performed at Seahorse's facility in North Billerica, Massachusetts over a one year period concluding in April 2017. No...
- This is a firm fixed-price purchase order contract awarded by the Plains Area federal agency to Seahorse Bioscience, Inc. for on-site PM (project management) services. The contract has a ceiling value of $3,950.00 and a completion date of January 30, 2015. The contract is not set aside for any specific program or business type. Seahorse Bioscience, Inc. is a for-profit organization and manufacturer of goods that is registered in the System for Award Management (SAM). The contract was awarded...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Seahorse Bioscience, Inc., a subsidiary of Agilent Technologies, Inc. The contract has a ceiling value of $63,602.00 and a completion date of June 2, 2021. No set-aside designation was used. The contract is for the provision of Seahorse Labware products, which are specialized laboratory equipment used in environmental health and scientific...
- This is a definitive contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the U.S. Department of Veterans Affairs, to Seahorse Bioscience, Inc. The contract is for the provision of Seahorse Bioscience Analyzers, with a firm fixed price of $174,892.00 and a completion date of December 23, 2015. The contract was not set aside for any specific business type. Seahorse Bioscience, Inc. is the prime contractor, and no subcontractors are mentioned. The...
- This is a $169,152.75 firm fixed price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to Agilent Technologies Inc. Customer Service And Sales Division. The contract is for a Seahorse XFe96 Analyzer, which is a specialized instrument used to measure the energy production pathways of live cells. The award was made on a sole source basis, as Agilent was determined to be the only vendor capable of meeting the agency's specific...
- <p>The federal contract award HHSN276201500020P is a $4,200.00 firm fixed price maintenance contract for a Seahorse XF24 instrument awarded to Seahorse Bioscience, Inc. by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency. The contract does not have a set-aside designation. The contract was awarded on October 28, 2014 and has an ultimate completion date of the same day.</p>
- This purchase order from the Department of Defense Uniformed Services University of the Health Sciences awards Government Scientific Source Inc. a $249,996.85 firm fixed price contract to deliver a SEAHORSE XFE96 Analyzer and five years of extended warranty services. The SEAHORSE XFE96 instrument measures oxygen consumption rates and extracellular acidification rates of live cells, supporting the DOD University's biomedical research efforts. Performance will take place in Herndon, Virginia...
- This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute, a civilian federal agency, to Agilent Technologies Inc. for maintenance services on a Seahorse XFE96 Analyzer. The contract has a ceiling value of $13,525.00 and an ultimate completion date of August 1, 2025. The award was not set aside and was competitively awarded. Agilent Technologies Inc. is a global manufacturer of advanced scientific instruments and laboratory equipment, and this award is part...
This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Seahorse Bioscience, Inc. for an "Extracellular Flux Analyzer" at a firm fixed price of $216,755.20. The contract was awarded on July 13, 2015 with a completion date of September 30, 2015. There was no set-aside designation for this award. Seahorse Bioscience, Inc. is the prime contractor, and the contract does not mention any major subcontractors. The FDA is the funding agency for this contract, which is likely related to their biomedical research and product evaluation programs.
Generated 5/16/25, 12:29 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Extracellular Flux Analysis | FDA-RFQ1146117 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 3/18/15, 10:00 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $216.8k | 7/13/15 |